Clínic Barcelona

IDIBAPS and IrsiCaixa participate in a 23 million euro project to develop HIV vaccine

IDIBAPS and the IrsiCaixa AIDS Research Institute participate in the European AIDS Vaccine Initiative (EAVI2020), a project to to accelerate the search for an effective HIV vaccine. This initiative, that is part of the European Comission framework programme for research and innovation (Horizon2020), brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA. IrsiCaixa and IDIBAPS are members of this consortium in which participate 22 institutions. Dr. Joan Joseph, researcher at the Infectious Diseases and AIDS IDIBAPS team led by Dr. Josep M. Gatell, will coordinate the project conducted at IDIBAPS over the next 5 years. At IrsiCaixa, an institute led by Dr. Bonaventura Clotet, this project will be coordinated by Dr. Christian Brander, head of the Host Cellullar and Genetic Immunity group and member of the consortium’s steering comitee. The other spanish participant in the consortium is the Instituto de Salud Carlos III.